| Literature DB >> 31798548 |
Brenda Oppert1, Lindsey Perkin2.
Abstract
Targeting genes via RNA interference (RNAi) has become a successful method to reduce pest populations. Ideally, the expression of a gene critical for a life function in the insect is targeted by specific dsRNA, via spray or oral delivery. Experts have developed working guidelines in the development and regulation of RNAi as a pesticide. We argue that an important tool in the validation of RNAi is genome-wide expression analysis in the targeted pest, and we name this approach RNAiSeq. We have used RNAiSeq in the coleopteran model Tribolium castaneum to validate knockdown of target genes, and to examine the effect of knockdown on other genes. With RNAiSeq, we identified compensation responses to the knockdown of a gene encoding a major digestive enzyme in larvae that correlated to the responses we have observed with ingested protease inhibitors. Compensation can mask RNAi phenotypic responses and is important to understand in the context of efficacy. RNAiSeq also has identified new gene interactions that were previously unassociated with the target gene, important in the context of the large number of genes without associated functions in insects and other organisms. We discuss other research where RNAiSeq has led to important findings. These data not only provide validation of target knockdown, but also further identify changes in the expression of other genes impacted by the knockdown. From the context of pest control, this information can be used to predict genetic changes that will impact the efficacy of RNAi products in target pests.Entities:
Keywords: RNASeq; Tribolium castaneum; gene expression; pest control product; stored product insect; topical RNAi
Year: 2019 PMID: 31798548 PMCID: PMC6868115 DOI: 10.3389/fmicb.2019.02570
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640
Figure 1Tribolium castaneum adult feeding on grain (photo courtesy USDA ARS, Peggy Greb).
Figure 2Cartoon depicting analysis from Case Study 1, data from Perkin et al., 2017a.
Figure 3Cartoon depicting analysis from Case Study 2, data from Perkin et al., 2017b.
Figure 4Cartoon depicting analysis from Case Study 3, data from Perkin and Oppert (2019).
Figure 5Differential expression of genes typically involved in RNAi (identified on the y axis) as determined by the fold change difference of treatment expression versus that of the control mock injected. CP D7, data from the cysteine peptidase study, analyzed at day 7 post injection (Perkin et al., 2017a); ADC D7 data were from Perkin et al. (2017b) analyzed at day 7 post injection; CPG D18 data were from Perkin and Oppert (2019) analyzed at day 18 post injection. Data that were significantly different (p < 0.05) indicated by asterisk.